<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2020-11-26-31</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-5750</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КАРДИОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CARDIOLOGY</subject></subj-group></article-categories><title-group><article-title>Структура факторов риска, коморбидных состояний и эмоциональных расстройств у больных инфарктом миокарда с фибрилляцией предсердий</article-title><trans-title-group xml:lang="en"><trans-title>Structure of risk factors, comorbid conditions and emotional disorders in patients with myocardial infarction with atrial fibrillation</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4486-3444</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Необутов</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Neobutov</surname><given-names>N. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Необутов Николай Николаевич, врач-кардиолог </p><p>170036, Тверь, Петербургское шоссе, д. 76/1</p></bio><bio xml:lang="en"><p>Nikolay N. Neobutov, cardiologist </p><p>76/1, Peterburgskoe Shosse, Tver, 170036</p></bio><email xlink:type="simple">gitarast16@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колбасников</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolbasnikov</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Колбасников Сергей Васильевич, д.м.н., профессор, заведующий кафедрой общей врачебной практики (семейной медицины) </p><p>170100, Тверь, ул. Советская, д. 4</p></bio><bio xml:lang="en"><p>Sergey V. Kolbasnikov, Dr. of Sci. (Med), Professor, Head of the Department of General Medical Practice (Family Medicine) </p><p>4, Sovetskaya St., Tver, 170100</p></bio><email xlink:type="simple">s.kolbasnikov@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Городская клиническая больница №7</institution><country>Россия</country></aff><aff xml:lang="en"><institution>City Clinical Hospital No 7</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Тверской государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Tver State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>06</day><month>08</month><year>2020</year></pub-date><volume>0</volume><issue>11</issue><fpage>26</fpage><lpage>31</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Необутов Н.Н., Колбасников С.В., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Необутов Н.Н., Колбасников С.В.</copyright-holder><copyright-holder xml:lang="en">Neobutov N.N., Kolbasnikov S.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/5750">https://www.med-sovet.pro/jour/article/view/5750</self-uri><abstract><p>Введение. Большинство пациентов с сердечно-сосудистыми заболеваниями в реальной медицинской практике характеризуются сочетанием двух и более заболеваний и состояний, т. е. коморбидностью. Это предъявляет дополнительные требования к наблюдению и лечению данной категории больных. Цель. Оценить факторы риска, структуру коморбидных состояний и выраженность психоэмоциональных расстройств у больных с инфарктом миокарда при различных формах фибрилляции предсердий. Материалы и методы. Обследовано 138 больных (63 мужчины, 75 женщин), находившихся на стационарном лечении в кардиологическом отделении ГБУЗ «Городская клиническая больница №7» с диагнозом «инфаркт миокарда с фибрилляцией предсердий». В зависимости от формы фибрилляции предсердий больные были распределены на две группы: 1-ю составили 83 (60,1%) больных с пароксизмальной формой, 2-ю группу – 55 (39,9%) с постоянной формой. Обследование проводилось в первые трое суток нахождения больных в стационаре. Результаты. У больных инфарктом миокарда с пароксизмальной формой фибрилляции предсердий в структуре факторов риска преобладает средняя степень никотиновой зависимости, опасное употребление алкоголя, высокое потребление поваренной соли и избыточная масса тела, а при постоянной форме фибрилляции предсердий регистрируется преимущественно слабая и высокая степень никотиновой зависимости, вредное употребление алкоголя и ожирение. Вывод. У больных инфарктом миокарда с пароксизмальной формой фибрилляции предсердий преобладающими факторами риска являются: опасное употребление алкоголя, высокое потребление поваренной соли и избыточная масса тела в сочетании с депрессивными расстройствами в виде субклинической и клинической депрессии, а при постоянной форме фибрилляции предсердий – высокая степень никотиновой зависимости и умеренно выраженные тревожные расстройства (субклинически и клинически выраженная тревога), что необходимо учитывать при проведении лечебно-профилактических, реабилитационных мероприятий и решении экспертных вопросов.</p></abstract><trans-abstract xml:lang="en"><p>Introduction: the majority of patients with cardiovascular diseases in real medical practice are characterized by a combination of two or more diseases and conditions, that is, comorbidity. This places additional demands on the observation and treatment of this category of patients. Objective: to assess risk factors, the structure of comorbid conditions and the severity of psychoemotional disorders in patients with myocardial infarction with various forms of atrial fibrillation. Materials and methods: 138 patients (63 men, 75 women) who were hospitalized in the cardiology department of the City Clinical Hospital No. 7 GBUZ with a diagnosis of myocardial infarction with atrial fibrillation were examined. Depending on the form of atrial fibrillation, the patients were divided into 2 groups: the 1st consisted of 83 (60,1%) patients with a paroxysmal form, the 2nd group – 55 (39,9%) with a constant form. The examination was carried out in the first three days of hospitalization of patients. Results: in patients with myocardial infarction with a paroxysmal form of atrial fibrillation, the structure of risk factors is dominated by an average degree of nicotine addiction, dangerous alcohol consumption, high salt intake and excess body weight, and with a constant form of atrial fibrillation, a mostly weak and high degree of nicotine addiction, harmful alcohol consumption and obesity.  Conclusion: in patients with myocardial infarction with a paroxysmal form of atrial fibrillation, the predominant risk factors are: dangerous alcohol consumption, high salt intake and overweight combined with depressive disorders in the form of subclinical and clinical depression, and with a constant form of atrial fibrillation, a high degree of nicotinic dependence and mild anxiety disorders: subclinically and clinically severe anxiety, which must be taken into account when carrying out preventive, rehabilitation measures and the solution of expert issues.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>инфаркт миокарда</kwd><kwd>фибрилляция предсердий</kwd><kwd>коморбидные состояния</kwd><kwd>эмоциональные расстройства</kwd><kwd>факторы риска</kwd><kwd>тревога</kwd><kwd>депрессия</kwd><kwd>сердечно-сосудистая коморбидность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>myocardial infarction</kwd><kwd>atrial fibrillation</kwd><kwd>comorbid conditions</kwd><kwd>emotional disorders</kwd><kwd>risk factors</kwd><kwd>anxiety</kwd><kwd>depression</kwd><kwd>cardiovascular comorbidity</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Шальнова С.А., Концевая А.М. Мониторинг факторов риска хронических неинфекционных заболеваний в практическом здравоохранении. М.; 2012. 27 с.</mixed-citation><mixed-citation xml:lang="en">Shalnova S.A., Kontsevaya A.M. Monitoring of risk factors for chronic noncommunicable diseases in health care practice. Moscow; 2012. 27 р. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Piepoli M.F., Hoes A.W., Agewall S., Albus C., Brotons C., Catapano A.L. et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention &amp; Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–2381. doi: 10.1093/eurheartj/ehw106.</mixed-citation><mixed-citation xml:lang="en">Piepoli M.F., Hoes A.W., Agewall S., Albus C., Brotons C., Catapano A.L. et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention &amp; Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–2381. doi: 10.1093/eurheartj/ehw106.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">DuGoff E.H., Canudas-Romo V., Buttorff C., Leff B., Anderson G.F. Multiple chronic conditions and life expectancy: a life table analysis. Med Care. 2014;52(8):688–694. doi: 10.1097/MLR.0000000000000166.</mixed-citation><mixed-citation xml:lang="en">DuGoff E.H., Canudas-Romo V., Buttorff C., Leff B., Anderson G.F. Multiple chronic conditions and life expectancy: a life table analysis. Med Care. 2014;52(8):688–694. doi: 10.1097/MLR.0000000000000166.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Оганов Р.Г., Денисов И.Н., Симаненков В.И. Бакулин И.Г., Бакулина Н.В., Болдуева С.А. и др. Коморбидная патология в клинической практике. Клинические рекомендации. Кардиоваскулярная терапия и профилактика. 2017;16(6):5–56. doi: 10.15829/1728-8800-2017-6-5-56.</mixed-citation><mixed-citation xml:lang="en">Oganov R.G., Denisov I.N., Simanenkov V.I., Bakulin I.G., Bakulina N.V., Boldueva S.A. еt al. Comorbidities in practice. Clinical guidelines. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2017;16(6):5–56. (In Russ.) doi: 10.15829/1728-8800-2017-6-5-56.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Лазебник Л.Б., Верткин А.Л., Конев Ю.В., Ли Е.Д., Скотников А.С. Старение: профессиональный врачебный подход. Национальное руководство. М.: Эксмо; 2014. 320 с.</mixed-citation><mixed-citation xml:lang="en">Lazebnik L.B., Vertkin A.L., Konev Yu.V., Li E.D., Skotnikov A.S. Aging: professional medical approach (National leadership). Moscow: Eksmo; 2014. 320 р. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Лазебник Л.Б., Конев Ю.В. Исторические особенности и семантические трудности использования терминов, обозначающих множественность заболеваний у одного больного. Экспериментальная и клиническая гастроэнтерология. 2018;(6):4–9. Режим доступа: https://www.nogr.org/jour/article/view/629#.</mixed-citation><mixed-citation xml:lang="en">Lazebnik L.B., Konev Yu.V. Historical features and semantic difficulties of using the terms denoting multiplicity of diseases in one patient. Ehksperimental’naya i klinicheskaya gastroehnterologiya = Experimental &amp; Clinical Gastroenterology. 2018;(6):4–9. (In Russ.) Available at: https://www.nogr.org/jour/article/view/629#.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Tilling L., Clapp B. Atrial fibrillation in myocardial infarction: predictors and prognosis. Int J Clin Pract. 2009;63(5):712–721. doi: 10.1111/j.1742-1241.2009.02061.x.</mixed-citation><mixed-citation xml:lang="en">Tilling L., Clapp B. Atrial fibrillation in myocardial infarction: predictors and prognosis. Int J Clin Pract. 2009;63(5):712–721. doi: 10.1111/j.1742-1241.2009.02061.x.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Neobutov N.N., Kolbasnikov S.V. The state of the myocardium, the vascular wall and the severity of anxiety-depressive disorders in patients with myocardial infarction and atrial fibrillation. Archiv Euromedica. 2019;9(1):109–112. doi: 10.35630/2199-885X/2019/9/1/109.</mixed-citation><mixed-citation xml:lang="en">Neobutov N.N., Kolbasnikov S.V. The state of the myocardium, the vascular wall and the severity of anxiety-depressive disorders in patients with myocardial infarction and atrial fibrillation. Archiv Euromedica. 2019;9(1):109–112. doi: 10.35630/2199-885X/2019/9/1/109.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Schotten U., Verheule S., Kirchhof P., Goette A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev. 2011;91(1):265–325. doi: 10.1152/physrev.00031.2009.</mixed-citation><mixed-citation xml:lang="en">Schotten U., Verheule S., Kirchhof P., Goette A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev. 2011;91(1):265–325. doi: 10.1152/physrev.00031.2009.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kirchhof P., Benussi S., Kotecha D., Ahlsson A., Atar D., Casadei B. et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893–2962. doi: 10.1093/eurheartj/ehw210.</mixed-citation><mixed-citation xml:lang="en">Kirchhof P., Benussi S., Kotecha D., Ahlsson A., Atar D., Casadei B. et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893–2962. doi: 10.1093/eurheartj/ehw210.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Pogosova N., Saner H., Pedersen S.S., Cupples M.E., McGee H., Höfer S. et al. Psychosocial aspects in cardiac rehabilitation: from theory to practice. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology. Eur J Prev Cardiol. 2015;22(10):1290–1306. doi: 10.1177/2047487314543075.</mixed-citation><mixed-citation xml:lang="en">Pogosova N., Saner H., Pedersen S.S., Cupples M.E., McGee H., Höfer S. et al. Psychosocial aspects in cardiac rehabilitation: from theory to practice. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology. Eur J Prev Cardiol. 2015;22(10):1290–1306. doi: 10.1177/2047487314543075.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Lichtman J.H., Froelicher E.S., Blumenthal J.A., Carney R.M., Doering L.V., Frasure-Smith N. et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 2014;129(12):1350–1369. doi: 10.1161/CIR.0000000000000019.</mixed-citation><mixed-citation xml:lang="en">Lichtman J.H., Froelicher E.S., Blumenthal J.A., Carney R.M., Doering L.V., Frasure-Smith N. et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 2014;129(12):1350–1369. doi: 10.1161/CIR.0000000000000019.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Винокур В.А., Гриневич В.Б., Ильяшевич И.Г., Курпатов В.И., Ледовая А.В., Оганезова И.А. и др.; Симаненков В.И. (ред.). Психосоматические расстройства в практике терапевта. СПб.: СпецЛит; 2008. 335 с.</mixed-citation><mixed-citation xml:lang="en">Vinokur V.A., Grinevich V.B., Ilyashevich I.G., Kurpatov V.I., Ledovaya A.V., Oganezova I.A. et al.; Simanenkov V.I. (ed.). Psychosomatic disorders in the practice of the therapist. St Petersburg: SpecLit; 2008. 335 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Гарганеева Н.П., Петрова М.М., Евсюков А.А., Штарик С.Ю., Каскаева Д.С. Влияние депрессии на особенности течения ишемической болезни сердца и качество жизни пациентов. Клиническая медицина. 2014;92(12):30–37. Режим доступа: http://www.medlit.ru/journalsview/clinicalmedicine/view/journal/2014/issue-12/743-vliyanie-depressii-natechenie-ishemicheskoy-bolezni-serdca-i-kachestvo-zhizni-pacientov.</mixed-citation><mixed-citation xml:lang="en">Garganeeva N.P., Petrova M.M., Evsyukov A.A., Kaskaeva D.S. The influence of depression on the course of coronary heart disease and quality of life. Klinicheskaya meditsina = Clinical Medicine. 2014;92(12):30–37. (In Russ.) Available at: http://www.medlit.ru/journalsview/clinicalmedicine/view/journal/2014/issue-12/743-vliyanie-depressii-na-techenie-ishemicheskoybolezni-serdca-i-kachestvo-zhizni-pacientov.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x.</mixed-citation><mixed-citation xml:lang="en">Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Saunders J.B., Aasland O.G., Babor T.F., de la Fuente J.R., Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption II. Addiction. 1993;88(6):791–804. doi: 10.1111/j.1360-0443.1993.tb02093.x.</mixed-citation><mixed-citation xml:lang="en">Saunders J.B., Aasland O.G., Babor T.F., de la Fuente J.R., Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption II. Addiction. 1993;88(6):791–804. doi: 10.1111/j.1360-0443.1993.tb02093.x.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Надеждин А.В., Тетенова Е.Ю., Шарова Е.В. Зависимость от никотина: диагностика и лечение. Медицина. 2016;(3):164–189. Режим доступа: https://stom.tilimen.org/jurnal-medicina-3-2016-164-164-zavisimoste-otnikotina-diagnos.html.</mixed-citation><mixed-citation xml:lang="en">Nadezhdin A.V., Tetenova E. Ju., Sharova E.V. Nicotine Dependence: Diagnosis and Treatment. Meditsina = Medicine. 2016;(3):164–189. (In Russ.) Available at: https://stom.tilimen.org/jurnal-medicina-3-2016-164-164-zavisimoste-ot-nikotina-diagnos.html.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerström K.O. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86(9):1119–1127. doi: 10.1111/ j.1360-0443.1991.tb01879.x.</mixed-citation><mixed-citation xml:lang="en">Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerström K.O. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86(9):1119–1127. doi: 10.1111/j.1360-0443.1991.tb01879.x.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Романова Н.П. Ограничение потребления поваренной соли с пищей как основной метод профилактики артериальной гипертонии. Губернские медицинские вести. 2000;3(5):6–8.</mixed-citation><mixed-citation xml:lang="en">Romanova N.P. Restriction of table salt consumption with food as the main method of arterial hypertension prevention. Gubernskie meditsinskie vesti = Provincial Medical News. 2000;3(5):6–8. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Weinberger M.H. Salt sensitivity as a predictor of hypertension. Am J Hypertens. 1999;(4):615–616.</mixed-citation><mixed-citation xml:lang="en">Weinberger M.H. Salt sensitivity as a predictor of hypertension. Am J Hypertens. 1999;(4):615–616.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Аметов А.С. Демидова Т.Ю., Целиковская А.Л. Ожирение и сердечнососудистые заболевания. Терапевтический архив. 2001;(8):69–72.</mixed-citation><mixed-citation xml:lang="en">Ametov A.S. Demidova T.Yu., Tselikovskaya A.L. Obesity and cardiovascular diseases. Terapevticheskiy arkhiv = Therapeutic Archive. 2001;(8):69–72.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Недогода С.В., Барыкина И.Н., Брель У.А., Бутрина Л.В., Чаляби Т.А. Ожирение и артериальная гипертензия. Часть I: снижение массы тела и нормализация артериального давления. Кардиоваскулярная терапия и профилактика. 2008;(5):105–115. Режим доступа: https://cardiovascular.elpub.ru/jour/article/view/1266.</mixed-citation><mixed-citation xml:lang="en">Nedogoda S.V., Barykina I.N., Brel U.A., Butrina L.V., Chalyabi T.A. Obesity and arterial hypertension. Part I: weight reduction and blood pressure normalisation. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2008;7(5):105–115. (In Russ.) Available at: https://cardiovascular.elpub.ru/jour/article/view/1266.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Панченко Е.П. Факторы риска сердечно-сосудистых заболеваний и подходы к их коррекции в начале XXI века (по материалам регистра REACH). Кардиоваскулярная терапия и профилактика. 2006;5(6):91–94. Режим доступа: https://elibrary.ru/item.asp?id=9956604.</mixed-citation><mixed-citation xml:lang="en">Panchenko E.P. Cardiovascular risk factors and their control in early XXI century (REACH registry data). Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2006;5(6):91–94. (In Russ.) Available at: https://elibrary.ru/item.asp?id=9956604.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Ивашкин В.Т., Драпкина О.М., Корнеева О.Н. Клинические варианты метаболического синдрома. М.: МИА; 2011. 208 с. Режим доступа: https://elibrary.ru/item.asp?id=19559614.</mixed-citation><mixed-citation xml:lang="en">Ivashkin V.T., Drapkina O.M., Korneeva O.N. Clinical options of the metabolic syndrome. Moscow: MIA; 2011. 208 p. (In Russ.) Available at: https://elibrary.ru/item.asp?id=19559614.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
